Lorin Andrew Thompson

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
- Patent number 12,109,198
- Issue date Oct 8, 2024
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich Efremov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
- Patent number 11,590,111
- Issue date Feb 28, 2023
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich Efremov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of p38 inhibitors to reduce expression of DUX4
- Patent number 11,479,770
- Issue date Oct 25, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 11,291,659
- Issue date Apr 5, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
- Patent number 10,973,805
- Issue date Apr 13, 2021
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich Efremov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 10,537,560
- Issue date Jan 21, 2020
- Fulcrum Therapeutics. Inc.
- Angela Marie Cacace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 10,342,786
- Issue date Jul 9, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Selective NR2B antagonists
- Patent number 9,221,796
- Issue date Dec 29, 2015
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-met...
- Patent number 9,187,506
- Issue date Nov 17, 2015
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the reduction of β-amyloid production
- Patent number 8,710,061
- Issue date Apr 29, 2014
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the reduction of beta-amyloid production
- Patent number 8,637,525
- Issue date Jan 28, 2014
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the reduction of beta-amyloid production
- Patent number 8,637,523
- Issue date Jan 28, 2014
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds for the reduction of beta-amyloid production
- Patent number 8,604,024
- Issue date Dec 10, 2013
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for the reduction of β-amyloid production
- Patent number 8,486,952
- Issue date Jul 16, 2013
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Succinoylamino lactams as inhibitors of a-β protein production
- Patent number 7,507,815
- Issue date Mar 24, 2009
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyalkanoylaminolactams and related structures as inhibitors of...
- Patent number 7,423,033
- Issue date Sep 9, 2008
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyalkanoylaminolactams and related structures as inhibitors of...
- Patent number 7,342,008
- Issue date Mar 11, 2008
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Succinoylamino lactams as inhibitors of Aβ protein production
- Patent number 7,304,055
- Issue date Dec 4, 2007
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Succinoylamino lactams as inhibitors of Aβ protein production
- Patent number 7,304,056
- Issue date Dec 4, 2007
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of small molecule radioligands to discover inhibitors of amyloi...
- Patent number 7,153,491
- Issue date Dec 26, 2006
- Bristol-Myers Squibb Pharma Company
- Robert Zaczek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hydroxyalkanoylaminolactams and related structures as inhibitors of...
- Patent number 7,112,583
- Issue date Sep 26, 2006
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Succinoylamino lactams as inhibitors of A-β protein production
- Patent number 7,101,870
- Issue date Sep 5, 2006
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein production
- Patent number 6,962,913
- Issue date Nov 8, 2005
- Bristol-Myers Squibb Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyalkanoylaminolactams and related structures as inhibitors of...
- Patent number 6,960,576
- Issue date Nov 1, 2005
- Bristol-Myers Squibb Pharma Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of small molecule radioligands to discover inhibitors of amyloi...
- Patent number 6,878,363
- Issue date Apr 12, 2005
- Bristol-Myers Squibb Pharma Company
- Robert Zaczek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Succinoylamino lactams as inhibitors of aβ protein
- Patent number 6,794,381
- Issue date Sep 21, 2004
- Bristol-Myers Squibb Company
- Richard E. Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of small molecule radioligands to discover inhibitors of amyloi...
- Patent number 6,737,038
- Issue date May 18, 2004
- Bristol-Myers Squibb Company
- Robert Zaczek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Succinoylamino carbocycles and heterocycles as inhibitors of a-&#x0...
- Patent number 6,525,044
- Issue date Feb 25, 2003
- Bristol-Myers Squibb Company
- Richard E Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxyalkanoylaminolactams and related structures as inhibitors of...
- Patent number 6,503,902
- Issue date Jan 7, 2003
- Bristol-Myers Squibb Pharma Company
- Richard Eric Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino lactam sulfonamides as inhibitors of Aβ protein produc...
- Patent number 6,503,901
- Issue date Jan 7, 2003
- Bristol-Myers Squibb Pharma Company
- Lorin Andrew Thompson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20240139163
- Publication date May 2, 2024
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4
- Publication number 20230257743
- Publication date Aug 17, 2023
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20220282254
- Publication date Sep 8, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20220160686
- Publication date May 26, 2022
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20220133704
- Publication date May 5, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20210121453
- Publication date Apr 29, 2021
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20200383963
- Publication date Dec 10, 2020
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20200360353
- Publication date Nov 19, 2020
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4
- Publication number 20200332291
- Publication date Oct 22, 2020
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20200297742
- Publication date Sep 24, 2020
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20200163949
- Publication date May 28, 2020
- Bristol-Myers Squibb Company
- Dalton King
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20190314358
- Publication date Oct 17, 2019
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20190314392
- Publication date Oct 17, 2019
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20190125770
- Publication date May 2, 2019
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20190117638
- Publication date Apr 25, 2019
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20190105311
- Publication date Apr 11, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20190105312
- Publication date Apr 11, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180250283
- Publication date Sep 6, 2018
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20180250316
- Publication date Sep 6, 2018
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180110766
- Publication date Apr 26, 2018
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20180104265
- Publication date Apr 19, 2018
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SELECTIVE NR2B ANTAGONISTS
- Publication number 20180000807
- Publication date Jan 4, 2018
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20170340653
- Publication date Nov 30, 2017
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective NR2B Antagonists
- Publication number 20170258777
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20170216325
- Publication date Aug 3, 2017
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20170065573
- Publication date Mar 9, 2017
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Selective NR2B Antagonists
- Publication number 20160081995
- Publication date Mar 24, 2016
- Bristol-Myers Squibb Company
- Dalton King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20160030456
- Publication date Feb 4, 2016
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
- Publication number 20150336975
- Publication date Nov 26, 2015
- Bristol-Myers Squibb Company
- Kenneth M. Boy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...
- Publication number 20150191496
- Publication date Jul 9, 2015
- Bristol-Myers Squibb Company
- Lorin A. Thompson
- C07 - ORGANIC CHEMISTRY

Lorin Andrew Thompson

Person

Patents Grantslast 30 patents

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

Use of p38 inhibitors to reduce expression of DUX4

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

Selective NR2B antagonists

(R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-met...

Compounds for the reduction of β-amyloid production

Compounds for the reduction of beta-amyloid production

Compounds for the reduction of beta-amyloid production

Compounds for the reduction of beta-amyloid production

Compounds for the reduction of β-amyloid production

Succinoylamino lactams as inhibitors of a-β protein production

Hydroxyalkanoylaminolactams and related structures as inhibitors of...

Hydroxyalkanoylaminolactams and related structures as inhibitors of...

Succinoylamino lactams as inhibitors of Aβ protein production

Succinoylamino lactams as inhibitors of Aβ protein production

Use of small molecule radioligands to discover inhibitors of amyloi...

Hydroxyalkanoylaminolactams and related structures as inhibitors of...

Succinoylamino lactams as inhibitors of A-β protein production

Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein production

Hydroxyalkanoylaminolactams and related structures as inhibitors of...

Use of small molecule radioligands to discover inhibitors of amyloi...

Succinoylamino lactams as inhibitors of a&#x03B2; protein

Use of small molecule radioligands to discover inhibitors of amyloi...

Succinoylamino carbocycles and heterocycles as inhibitors of a-&#x0...

Hydroxyalkanoylaminolactams and related structures as inhibitors of...

Amino lactam sulfonamides as inhibitors of A&#x03B2; protein produc...

Patents Applicationslast 30 patents

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

SELECTIVE NR2B ANTAGONISTS

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

SELECTIVE NR2B ANTAGONISTS

SELECTIVE NR2B ANTAGONISTS

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

SELECTIVE NR2B ANTAGONISTS

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

SELECTIVE NR2B ANTAGONISTS

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

SELECTIVE NR2B ANTAGONISTS

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

SELECTIVE NR2B ANTAGONISTS

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

Selective NR2B Antagonists

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

Selective NR2B Antagonists

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-MET...

Succinoylamino lactams as inhibitors of aβ protein

Amino lactam sulfonamides as inhibitors of Aβ protein produc...